Characterization of mouse thrombin-activatable fibrinolysis inhibitor

Thrombosis and Haemostasis

Volumn 83, Issue 2, 2000, Pages 297-303

  Marx, Pauline F ^a,b   Wagenaar, Gerry T M ^a,b   Reijerkerk, Arie ^a   Tiekstra, Margriet J ^a,b   Van Rossum, Agnes G S H ^a,b   Gebbink, Martijn F B G ^a   Meijers, Joost C M ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation; Fibrinolysis; Thrombin activatable fibrinolysis inhibitor

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR;

ARTICLE; BLOOD CLOTTING; DNA SEQUENCE; FIBRINOLYSIS; GENE EXPRESSION; HUMAN; LIVER; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033974223     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613802     Document Type: Article

References (32)

1. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-84.
2. Nesheim M, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 1997; 78: 386-91.
3. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxy peptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 1996; 271: 16603-8.
4. Bouma BN, Von dem Borne PA, Meijers JC. Factor XI and protection of the fibrin clot against lysis- a role for the intrinsic pathway of coagulation in fibrinolysis. Thromb Haemost 1998; 80: 24-7.
5. Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 1991; 266: 21833-8.
6. Wang W, Hendriks DF, ScharpJ SS, Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 1994; 269: 15937-44.
7. Vanhoof G, Schatteman K, Goossens F, Scharpé S, Hendriks DF. Procarboxypeptidase U is expressed in human liver. Fibrinol Proteol 1997; 11: 41.
8. Bajzar L, Nesheim ME, Tracy PB. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 1996; 88: 2093-100.
9. Mosnier LO, Von dem Borne PA, Meijers JC, Bouma BN. Plasma TAFI levels determine the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation. Thromb Haemost 1998; 80: 829-35.
10. Suenson E, Lutzen O, Thorsen S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem 1984; 140: 513-22.
11. Norrman B, Wallen P, Ranby M. Fibrinolysis mediated by tissue plasminogen activator. Disclosure of a kinetic transition. Eur J Biochem 1985; 149: 193-200.
12. Redlitz A, Tan AK, Eaton DL, Plow EF. Plasma carhoxypeptidases as regulators of the plasminogen system. J Clin Invest 1995; 96: 2534-8.
13. Boffa MB, Wang W, Bajzar L, Nesheim ME. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J Biol Chem 1998; 273: 2127-35.
14. Nesheim ME, Boffa MB, Wang W. The effects of temperature. GEMSA, and EACA on the stability of activated TAFI. Fibrinolysis 1996; 10: 126.
15. Boffa M, Reid ST, Joo E, Nesheim M, Koschinsky ML. Characterisation of the gene encoding human TAFI (Thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B). Biochein 1999; 38: 6547-58.
16. Vanhoof G, Wauters J, Schatteman K, Hendriks D, Goossens F, Bossuyt P, Scharpé S. The gene for human carboxypeptidase U (CPU) - a proposed novel regulator of plasminogen activation - maps to 13q14,11. Genomics 1996; 38: 454-5.
17. Tsai SP, Drayna D. The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13. Genomics 1992; 14: 549-50.
18. Von dem Borne PA, Meijers JC, Bouma BN. Feedback activation of Factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 1995; 86: 3035-42.
19. Brunner J, Skrabal P, Hauser H. Single hilayer vesicles prepared without sonication. Physico-chemical properties. Biochim Biophys Acta 1976; 455: 322-31.
20. Rouser G, Fleisher S, Yamamoto A. Two dimensional thin layer Chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970; 5: 494-6.
21. Lennon GG, Auffray C, Polymeropoulos M, Soares MB. Generation and analysis of 280,000 human expressed sequence tags. Genomics 1996; 33: 151-2.
22. Chomezynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
23. Sambrook J, Fritsch EF, Maniatis T. Extraction, purification, and analysis of messanger RNA from eukaryotic cells. In: Molecular cloning: a laboratory manual. Nolan C., ed. Cold Spring Harbor. New York: Cold Spring Harbor Laboratory Press 1989; 7.3-7.8.
24. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
25. Henderson C. Aminoalkylsilane: an inexpensive, simple preparation for slide adhesion. J Histotechnol 1989; 12: 123-4.
26. Wilkinson DG. In: In situ hybridization. A practical approach. Rickwood, D, Hames, BD, series eds. Oxford and New York: Oxford University Press, 1992.
27. Meijers JC, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992; 79: 1435-40.
28. Hendriks DF, Wang W, Scharpé SS, Lommaert M, Van Sande M. Purification and characterization of a new arginine carboxypeptidase in human serum. Biochym et Biophys Acta 1990; 1034: 86-92.
29. Hendriks D, Lommaert M, Van Sande M. Charactcrization of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 1989; 27: 277-85.
30. Boffa M, Nesheim ME. Analysis of a recombinant form of human TAFI (plasma procarboxypeptidase B) containing an Arg to GIn substitution at the inactivation cleavage site. Thromb Haemost 1997; supplement: 596.
31. Zhao L, Morser J, Bajzar L. Nesheim M, Nagashima M. Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms. Thromb Haemost 1998; 80: 949-55.
32. Jungermann K, Katz N. Functional specialisation of different hepatocyte populations. Physiol Rev 1989; 69: 708-64.